Spyre Therapeutics, Inc. (SYRE) Net Income by Year
Spyre Therapeutics, Inc. reported a net loss of $155.2M in fiscal year 2025. This represents an increase of 25.4% from the prior fiscal year. The table below carries 12 fiscal years, from 2014 to 2025, and the quarters Spyre Therapeutics, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
SYRE Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
SYRE Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More Spyre Therapeutics, Inc. financials
Frequently Asked Questions
What was Spyre Therapeutics, Inc.'s net income in fiscal year 2025?
Spyre Therapeutics, Inc. reported a net loss of $155.2M in fiscal year 2025.
How fast is Spyre Therapeutics, Inc.'s net income growing?
Spyre Therapeutics, Inc. (SYRE) net income rose by 25.4% year over year, from -$208.0M to -$155.2M in fiscal year 2025.
How has Spyre Therapeutics, Inc.'s net income changed over the years?
Across the 12 fiscal years this page covers, Spyre Therapeutics, Inc. (SYRE) net income went from -$10.3M in fiscal year 2014 to -$155.2M in fiscal year 2025.
What was Spyre Therapeutics, Inc.'s net income in the most recent quarter?
Spyre Therapeutics, Inc. (SYRE) reported -$36.2M in net income in Q2 2026. This represents an increase of 1.4% from the same quarter a year earlier.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Spyre Therapeutics, Inc. (SYRE) reported on that line in every period on record.